Cite
HARVARD Citation
Yonekura, K. et al. (2014). Effect of anti‐CCR4 monoclonal antibody (mogamulizumab) on adult T‐cell leukemia–lymphoma: Cutaneous adverse reactions may predict the prognosis. Journal of dermatology. 41 (3), pp. 239-244. [Online].